Literature DB >> 29281577

Toward Better-Quality Compounded Drugs - An Update from the FDA.

Janet Woodcock1, Julie Dohm1.   

Abstract

Mesh:

Year:  2017        PMID: 29281577     DOI: 10.1056/NEJMp1712905

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Thyrotoxicosis due to 1000-fold error in compounded liothyronine: A case elucidated by mass spectrometry.

Authors:  Wajid Khan; Grace Van Der Gugten; Daniel T Holmes
Journal:  Clin Mass Spectrom       Date:  2018-11-30

2.  Systemic Adverse Events Associated with Compounded Topical Pain Products.

Authors:  Jenny Kim; Karen Konkel; S Christopher Jones; Lynda McCulley
Journal:  Drug Saf       Date:  2020-05       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.